158 related articles for article (PubMed ID: 38141603)
1. Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review.
Bovo AC; Pedrão PG; Guimarães YM; Godoy LR; Resende JCP; Longatto-Filho A; Reis RD
Rev Bras Ginecol Obstet; 2023 Dec; 45(12):e818-e824. PubMed ID: 38141603
[TBL] [Abstract][Full Text] [Related]
2. The combined oral contraceptive. Risks and adverse effects in perspective.
Bagshaw S
Drug Saf; 1995 Feb; 12(2):91-6. PubMed ID: 7766340
[TBL] [Abstract][Full Text] [Related]
3. [Combined oral contraception and the risk of reproductive organs cancer in women].
Medard M L; Ostrowska L
Ginekol Pol; 2007 Aug; 78(8):637-41. PubMed ID: 18050614
[TBL] [Abstract][Full Text] [Related]
4. Hormonal contraception--what kind, when, and for whom?
Wiegratz I; Thaler CJ
Dtsch Arztebl Int; 2011 Jul; 108(28-29):495-505; quiz 506. PubMed ID: 21814535
[TBL] [Abstract][Full Text] [Related]
5. Combined oral contraceptives: risks and benefits.
Thorogood M; Villard-Mackintosh L
Br Med Bull; 1993 Jan; 49(1):124-39. PubMed ID: 8324603
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives and reproductive system cancer.
Deligeoroglou E; Michailidis E; Creatsas G
Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827
[TBL] [Abstract][Full Text] [Related]
7. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
Syrjänen K
Eur J Gynaecol Oncol; 2008; 29(3):205-21. PubMed ID: 18592782
[TBL] [Abstract][Full Text] [Related]
8. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
Castellsagué X; Muñoz N
J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.
; Appleby P; Beral V; Berrington de González A; Colin D; Franceschi S; Goodhill A; Green J; Peto J; Plummer M; Sweetland S
Lancet; 2007 Nov; 370(9599):1609-21. PubMed ID: 17993361
[TBL] [Abstract][Full Text] [Related]
10. Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.
Harris TG; Miller L; Kulasingam SL; Feng Q; Kiviat NB; Schwartz SM; Koutsky LA
Am J Obstet Gynecol; 2009 May; 200(5):489.e1-8. PubMed ID: 19375566
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.
Julkunen HA
Scand J Rheumatol; 1991; 20(6):427-33. PubMed ID: 1771400
[TBL] [Abstract][Full Text] [Related]
13. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under.
Hoyo C; Cousins DS; Bisgrove EZ; Gaines MM; Schwingl PJ; Fortney JA
West Indian Med J; 2004 Dec; 53(6):406-12. PubMed ID: 15816269
[TBL] [Abstract][Full Text] [Related]
14. Risk of cancer development in relation to oral contraception.
Lech MM; Ostrowska L
Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):162-8. PubMed ID: 17056445
[TBL] [Abstract][Full Text] [Related]
15. Combined oral contraceptives: acceptability and effective use.
Kubba A; Guillebaud J
Br Med Bull; 1993 Jan; 49(1):140-57. PubMed ID: 8324604
[TBL] [Abstract][Full Text] [Related]
16. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
17. The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review.
Anastasiou E; McCarthy KJ; Gollub EL; Ralph L; van de Wijgert JHHM; Jones HE
Contraception; 2022 Mar; 107():1-9. PubMed ID: 34752778
[TBL] [Abstract][Full Text] [Related]
18. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
19. Correlation between cervical carcinogenesis and tobacco use by sexual partners.
Siokos AG; Siokou-Siova O; Tzafetas I
Hell J Nucl Med; 2019; 22 Suppl 2():184-190. PubMed ID: 31802062
[TBL] [Abstract][Full Text] [Related]
20. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.
Kjellberg L; Hallmans G; Ahren AM; Johansson R; Bergman F; Wadell G; Angström T; Dillner J
Br J Cancer; 2000 Apr; 82(7):1332-8. PubMed ID: 10755410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
